リウマチ性関節炎の制御における腸内微生物群-免疫軸:メカニズムから精密なプロバイオティック戦略へ
1Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Modern rheumatology
|August 29, 2025
まとめ
リウマチ性関節炎 (RA) は,腸の機能不全を伴うもので,免疫のバランスを乱します. プロバイオティクスは RA患者の腸の健康を回復し 免疫反応を調節することで パーソナライズされた治療の 可能性を示しています
科学分野:
- 免疫学
- 微生物群の研究
- 胃腸内科
背景:
- リウマチ性関節炎 (RA) は慢性的な自己免疫疾患で,健康と経済的負担が大きい.
- 現在のRA治療は 副作用,費用,患者の反応の変動などに 直面しています
- 腸内微生物群と免疫系は RA の発症と進行の 重要な要因として認識されています
研究 の 目的:
- リウマチ性関節炎の病原性における腸内微生物と免疫の相互作用の役割を検討する.
- 精密治療法としてプロバイオティクスの 治療の可能性を探る
- 個々の宿主と微生物群の要因に基づいたパーソナライズされたプロバイオティック戦略の必要性を強調する.
主な方法:
- RAにおける腸内微生物群を調査する研究の文献レビュー
- 腸内微生物群と免疫系を対象としたプロバイオティクスの研究分析
- RAと微生物群に関連するマルチオミクスデータと臨床試験結果の合成
主要な成果:
- RA患者は腸内不活性症を呈し,その特徴は微生物の組成の変化と腸内バリア機能の障害である.
- Th17/Tregの不均衡と全身の炎症を含む免疫不調に寄与する.
- プロバイオティクスは腸内微生物群を調節し,腸内バリアの整合性を高め,臨床前および臨床RAモデルにおける免疫反応を調節することができます.
結論:
- 腸内微生物群と免疫軸は 新しいRA治療の有望なターゲットです
- パーソナライズされたプロバイオティクスの介入は,マルチオミックスのデータに基づいて,RAにおける精密医療の可能性を秘めています.
- 微生物群によるRA管理を進めるために,大規模な試験とバイオマーカーの発見を含むさらなる研究が必要です.
関連する概念動画
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Inflammatory Response
7.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.0K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K


